Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Danaher Corporation

How Is Danaher’s Stock Performance Compared to Medical Devices Stocks

Danaher has underperformed the Medical Devices industry, though Wall Street analysts remain strongly optimistic about its future prospects.

Barchart

3 Healthcare Stocks Benefiting From an Aging Population

The healthcare industry is poised for tremendous growth driven by the aging population and rising incidence of chronic diseases. Hence, quality healthcare stocks, Danaher (DHR), Amgen (AMGN), and DexCom (DXCM), benefiting from an aging population, might be worth looking into. Read more….

StockNews.com

Is Danaher Corporation Stock Outperforming the Dow?

Danaher Corporation recently reached an all-time high, outperforming the Dow Jones, with Wall Street analysts remaining moderately bullish about its prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Veralto: The Unassuming ESG Powerhouse That Will Likely Double

In the specialized field of spinoff companies, Veralto emerges as a prime investment opportunity, stemming from its recent spinoff from Danaher Corporation.

Barchart

Danaher (DHR) vs. Stryker (SYK) - Analyzing Anticipated Q4 Earnings

With rapidly increasing healthcare demands, numerous technological breakthroughs, and advanced research and development, the medical industry is well-poised for remarkable growth and profitability. As medical companies Danaher (DHR) and Stryker (SYK) gear to report their fourth-quarter earnings tomorrow, let’s determine if these stocks are ideal buys ahead of earnings….

StockNews.com

Xpert MTB/RIF molecular test for tuberculosis diagnosis to cost 20% less

Danaher Corporation, which sells the Xpert MTB/RIF molecular test for diagnosing tuberculosis (TB) and rifampicin resistance, has announced a lowering of the price of its standard TB test cartridge

The Hindu

Are These 3 Medical Stocks Worth Buying?

The increased demand for healthcare services and technological advancements are poised to keep the healthcare industry buoyed in the foreseeable future. Given this backdrop, are medical stocks Danaher Corporation (DHR), IQVIA Holdings (IQV), and Bio-Rad Laboratories (BIO) worth buying now? Read on to find more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 of the Strongest Stocks to Buy Right Now

Rekindled recession worries amid upheaval in the banking sector and the Fed’s further tightening of monetary policy could keep the stock market volatile in the near term. Given this backdrop, we think the strong growth prospects of UnitedHealth Group (UNH), Danaher Corp. (DHR), and ServiceNow (NOW) make these stocks solid…

StockNews.com

DC billionaire partnering with Josh Harris in attempt to buy the Commanders

Are we getting closer to a potential sale?

USA Today Sports Media Group

2 Stocks to Buy Now at Knocked-Down Prices

With steady growth in employment during November, slower but surer interest rate hikes by the Fed to fight inflation threaten to keep markets subdued and the economy sluggish next year. Therefore, it could be wise to load up on shares of businesses with robust demand and a stable growth trajectory,…

StockNews.com

2 Deeply Discounted Stocks to Buy Now

The Fed’s aggressive monetary policy stance and high inflation levels have led to a broad stock market sell-off this year. Analysts continue to expect a recession with minimal chances of a soft landing. As value investing gains traction, fundamentally sound stocks Microsoft (MSFT) and Danaher (DHR), which are trading at…

StockNews.com

This Pandemic Star Is Embroiled in CEO Drama

Maravai LifeSciences had to undo a recent CEO change due to a lawsuit. Luckily, the drama should be resolved quickly.

The Street

Jim Cramer Likes This Stock Over Olaplex

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Danaher Corporation (NYSE: DHR) over InMode Ltd. (NASDAQ: INMD).

Benzinga

Danaher's Defensive Portfolio Is Ideal Amid Macro Fears: RBC Analyst

Danaher Corporation’s (NYSE: DHR) portfolio, with 75% recurring revenues and more than a 90% mix in life sciences and diagnostics, appears “incrementally more attractive” amid the currently harsh macro environment, according to RBC Capital Markets.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

4 Beaten-Down Dividend Growth Stocks to Scoop Up Now

The major benchmark indices posted their best day since mid-March on Tuesday. However, with the International Monetary Fund (IMF) reducing its global economic growth forecast, citing the Russia-Ukraine war and rising inflation as key contributors, the market could remain volatile in the near term. Thus, we think beaten-down dividend stocks…

Benzinga

Looking Into Danaher Corporation's Recent Short Interest

Danaher Corporation's (NYSE:DHR) short percent of float has fallen 25.88% since its last report. The company recently reported that it has 4.09 million shares sold short, which is 0.63% of all regular shares that are available for trading.

StockNews.com

5 Top Mega-Cap Stocks in the Healthcare Sector to Buy This Month

The healthcare sector is known for its defensive qualities. Therefore, betting on mega-cap healthcare stocks could be one of the best ways to generate stable returns amid the current, extended, market volatility. We think their solid growth attributes and profit margins make the stocks of Novartis (NVS), Danaher (DHR), Eli…

Benzinga

How Is The Market Feeling About Danaher Corporation?

Danaher Corporation's (NYSE:DHR) short percent of float has risen 10.67% since its last report. The company recently reported that it has 5.31 million shares sold short, which is 0.83% of all regular shares that are available for trading.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Danaher Q4 Results Beat Expectations, Clocks 21% Jump In Sales

Danaher Corporation (NYSE: DHR)

People

Adam Schefter

1,861 stories

Mangeet Kaur BounsMangeet

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Washington Commanders

Microsoft Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.